Posted by Michael Wonder on 10 Jul 2019
FDA approves Katerzia, the first and only amlodipine oral suspension for paediatric patients 6 years of age and older
10 July 2019 - Azurity Pharmaceuticals announced today that the U.S. FDA has approved Katerzia (amlodipine) 1 mg/mL oral suspension, the first and only FDA approved amlodipine oral suspension.
Katerzia is indicated for the treatment of hypertension in adults and paediatric patients 6 years of age and older and coronary artery disease in adults.
Read Azurity Pharmaceuticals press release
